Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Study Phase : Phase II
Recipient : Harry T Whelan
Deal Size : Inapplicable
Deal Type : Inapplicable
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Details : Porfimer Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Brain Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 22, 2013
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase II
Recipient : Harry T Whelan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Study Phase : Phase I
Recipient : Harry T Whelan
Deal Size : Inapplicable
Deal Type : Inapplicable
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Details : Porfimer Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Brain Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 11, 2012
Lead Product(s) : Photofrin Porfimer Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase I
Recipient : Harry T Whelan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
Details : This drug candidate is currently being evaluated in phase II clinical studies for the treatment of Dysplasia-associated with Barrett Esophagus.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 08, 2010
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
